Shedding Light on Osteosarcoma Cell Differentiation: Impact on Biomineralization and Mitochondria Morphology

Int J Mol Sci. 2023 May 10;24(10):8559. doi: 10.3390/ijms24108559.

Abstract

Osteosarcoma (OS) is the most common primary malignant bone tumor and its etiology has recently been associated with osteogenic differentiation dysfunctions. OS cells keep a capacity for uncontrolled proliferation showing a phenotype similar to undifferentiated osteoprogenitors with abnormal biomineralization. Within this context, both conventional and X-ray synchrotron-based techniques have been exploited to deeply characterize the genesis and evolution of mineral depositions in a human OS cell line (SaOS-2) exposed to an osteogenic cocktail for 4 and 10 days. A partial restoration of the physiological biomineralization, culminating with the formation of hydroxyapatite, was observed at 10 days after treatment together with a mitochondria-driven mechanism for calcium transportation within the cell. Interestingly, during differentiation, mitochondria showed a change in morphology from elongated to rounded, indicating a metabolic reprogramming of OS cells possibly linked to an increase in glycolysis contribution to energy metabolism. These findings add a dowel to the genesis of OS giving new insights on the development of therapeutic strategies able to restore the physiological mineralization in OS cells.

Keywords: biomineralization; bone cancer; calcium L-edge; cryo-XANES; mitochondria; osteoblastic differentiation; osteogenic sarcoma.

MeSH terms

  • Biomineralization
  • Bone Neoplasms* / metabolism
  • Cell Differentiation / physiology
  • Cell Line, Tumor
  • Cell Proliferation / physiology
  • Humans
  • Mitochondria / metabolism
  • Osteogenesis
  • Osteosarcoma* / metabolism

Grants and funding

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under iNEXT-Discovery project grant agreement No. 871037.